|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.2935 - 0.2935|
|52 Week Range||0.0160 - 0.5400|
|Beta (3Y Monthly)||1.21|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
If you invest in marijuana penny stocks, you are probably aware that over the past year many of the companies in this risky sector of the equity markets have seen significant declines in their share prices.Many of these little companies had stocks that were trading for $2 or $3 a share or even more during the ball of last year. This was due to expectations and excitement leading up to Canadian legalization. Since then, the share prices of most of these companies have fallen to just a few pennies. Once this happens, it is basically over. Very few of them will survive.The following seven companies seem to have weathered the storm over the past year. This could be an indication that they may have favorable prospects for the future. If they survive the bad times maybe they will prosper in the good times. Because of this, they are on my radar screen as potential buys.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Retail Stocks to Buy for the Second Half of 2019 Please understand that these are not recommendations. It is just a starting point for my analysis. I will be doing some more research into these companies before potentially may be making investments in them. Marijuana Penny Stocks: 48North Cannabis Corp (NRTH)48North Cannabis Corp (CVE:NRTH) produces and sells medical cannabis. It focuses on the female health and wellness market. This company is on the list because of the huge increases of trading volume that have occurred. In a situation like this, increasing volume could be a bullish signal.This is an important dynamic to understand. Stocks do not need volume to head lower, but they do need meaningful volume to go higher. This is because investors do not need to buy, but they may need to sell.For example, consider a fictional stock with every shareholder content with their positions. Buyers will not buy more, and sellers will not want to sell any.However, now suppose that one of these holders needs to raise money for an unforeseen emergency. They will be forced to sell. Because at current levels there is no buy interest, the stock will inevitably go lower because they will be forced to sell at lower prices.This increasing interest could be due to some recent news. NRTH stock's Good:House farm expects its first outdoor harvest in August, and is converting another location from cultivation to propagation, processing and packaging. This is important because outdoor marijuana is significantly cheaper to grow than greenhouse marijuana.Most marijuana is grown indoors because it is considered more secure and of better quality. But due to the huge cost advantage, investors are starting to consider outdoor growing. Two Rivers Water & Farming (TURV)Two Rivers Water & Farming (OTCMKTS:TURV) acquires and develops farmland and associated water rights. It provides greenhouses and processing facilities for marijuana growers in Colorado with water rights not used for fruit and vegetable production.TURV got my attention because the stock has been mostly trending higher since March. Maybe it is doing well because this company is different than most other penny stock companies. Two Rivers actually makes money. Last earnings report, it revealed earnings of 9 cents per share. * 10 Best Stocks for 2019: A Volatile First Half There has also been some recent positive news. The company just announced a new pilot project to manage hemp production on a large farm in Colorado. Management believes that this will pave the way for further expansion. National Access Cannabis Corp (NACNF)National Access Cannabis Corp (OTCMKTS:NACNF) is a recreational cannabis retailer in Canada.This retailer may be in a great position to profit from the enormous growth of the cannabis industry. A frequently mentioned report by Arcview Market Research and BDS Analytics states consumer spending on cannabis may increase by almost 40% this year.National Access currently operates 23 stores in Canada. Since cannabis became legal in October the company has had about $27 CAD million of sales with impressive gross margins that are around 31%.By the end of the year, the company plans to have 40 stores opened and operating. With this rate of anticipated growth, this company may have great future potential. Pivot Pharmaceuticals Inc (PVOTF)Pivot Pharmaceuticals Inc (OTCMKTS:PVOTF) is an early stage pharmaceutical company that engages in the development and commercialization of therapeutic and nutraceutical products.PVOTF has been acting well since April. This may be due to the fact the company just hired an experienced chief operating officer to strengthen its management team.The cannabis industry is full of incompetent management. Many entrepreneurs may have great ideas and can get a company up and running, but they do not have the skills to manage the company as it grows and matures. Pivot's recognition of the need for experienced people could be a good sign. * 7 A-Rated Stocks to Buy for the Rest of 2019 It also announced that it is expanding its Board of Directors. This move could attract investors. Some investors think the composition of the Board is extremely important and analyze it as part of their investment research process. Cannabics Pharmaceuticals Inc (CNBX)Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) is an early stage biotechnology company that develops personalized anti-cancer and palliative treatments.There is a very cool story here. This company is trying to develop medicinal marijuana that will treat and potentially cure cancer. But CNBX stock got my attention because it is trading at a level that has been support in the past. After finding support at these levels in December, the stock more than doubled.An important thing to consider here is that in its most recent quarter, CNBX stock reported earnings of 3 cents per share. That doesn't sound too impressive at first glance, but when you consider that most of these other penny-stock marijuana companies are losing money, you can understand the significance.Now that CNBX stock is on my radar screen, I will be watching it to see if this support holds over the next month or two. If so, I will do some more research. Earth Science Tech Inc. (ETST)Earth Science Tech Inc. (OTCMKTS:ETST) researches and develops cannabis and industrial hemp.This company holds a portfolio of diverse subsidiaries. In early June, the stock dipped to lows around 30 cents. Since then, the stock has rallied.This company caught my attention due to the extensive experience of the management team and advisory board. As I said before, many of these little marijuana companies are run by inexperienced people. ETST stock appears to be different. * 7 Retail Stocks to Buy for the Second Half of 2019 Chief Financial Officer Wendell Hecker has more than 30 years of experience in large New York City based corporations. The chief operations officer and the chief sales officer are also veterans. They each have more than two decades of experience. To see insiders with this amount of experience is unusual in this industry. Halo Labs (AGEEF)Halo Labs (OTCMKTS:AGEEF) develops and manufactures cannabis oils and concentrates.This company caught my attention because despite some volatility, it has trended higher since the beginning of the year. In January it was trading around 22 cents and the most recent close was 42 cents.There have been some developments at Halo that seem to be positive. This is what could be driving this move.Last month, the company reported that its revenues had tripled to almost $9 million. This was attributed to the launching of cannabis oil and concentrate operations in Canada and Nevada.In addition to this, AGEEF stock started trading on the OTCQX. This is one of the tiers or levels of the Canadian OTC Market. Before this, it traded on a lower tier.Because the higher tier requires more transparency and disclosure, some investors may consider this to be a positive development for the long-term prospects of the company.As of this writing, Mark Putrino did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks to Buy on College Students' Radars * 7 Retail Stocks to Buy for the Second Half of 2019 * The S&P 500's 5 Best Highest-Yielding Dividend Stocks The post 7 Marijuana Penny Stocks That I May Buy appeared first on InvestorPlace.
VANCOUVER , July 9, 2019 /PRNewswire/ - Pivot Pharmaceuticals Inc . (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT ) ("Pivot" or the "Company") announces that it has hired Mr. Russell Starr ...
Pivot will use the remaining proceeds from the non-brokered private placement to execute on product manufacturing, distribution and sales beginning in the European Union, where regulations permit. Further, Pivot will use the proceeds to commence operations in Montreal, Canada where it is working with Health Canada to obtain its Standard Processor and Medical Sales Licenses. Concurrently with the closing of the Offering, Joe Mimran and Dr. Kenneth Kessler joined the Advisory Board of Pivot and Krisztian Toth joined the Board of Directors of Pivot as Executive Chairman and Dr. Joseph Borovsky will serve as the Lead Director.
Pivot's micellized CBD oral solution, is a revolutionary product for the emerging cannabis industry. SolMic's CEO, Dr. Wolfgang Schoenfeld stated, "The entire SolMic team is thrilled to be working with Pivot Pharma. Production of the miCelleBD oral solution has been initiated and our sales and marketing team has begun to take orders from clients, including from a network of 2,000 pharmacies in Germany and Switzerland .
Each Unit consists of one common share of the Company ("Common Share") and one Common Share purchase warrant of the Company ("Warrant"). Each whole Warrant shall be exercisable for a period of two years from the closing date of the Offering to purchase one Common Share at a price of $0.35 per Common Share.
The private placement will be of units at a price of $0.25 per unit, with each unit consisting of one common share and one common share purchase warrant ("Warrants") having a term of two years and an exercise price of $0.35. The private placement is expected to close in two tranches, with the first closing of $5 million within two weeks and the second tranche of $10 million closing within four weeks. Upon completion of the non-brokered private placement Pivot will issue 60,000,000 units to HPK. Completion of the private placement is conditional on HPK satisfactorily completing its due diligence investigation and High Park Ventures and Pivot entering into an advisory agreement pursuant to which High Park Ventures will provide Pivot with strategic advice.
Pharmascience is the 4th largest manufacturer of over-the-counter generic drugs in the country and is a leading manufacturer and marketer of prescription generic, over-the-counter, and behind-the-counter products as well as FDA approved Canadian-made injectables. In Canada alone, more than 45 million prescriptions a year are filled with Pharmascience products. Pivot's CEO, Dr. Patrick Frankham stated, "We are thrilled that Pharmascience has agreed to collaborate with Pivot as we prepare to commercialize our bio-cannabis product line.
As previously disclosed, Pivot has invested significantly in the acquisition and licensing of patented drug delivery technologies, developed differentiated cannabis formulations using pharmaceutical grade CBD and THC isolates as active ingredients, and worked with our network of pharma product experts to create the largest catalogue of bioavailable, stable and effective cannabis products. All of Pivot's products will be marketed under "Pivot Naturals" brand, will be manufactured at cGMP accredited facilities in Canada , California and the EU, and will be distributed direct-to-consumer in Canada via Shopify. "Pivot will leverage the full power of Shopify's e-commerce platform to create a state-of-the-art, online destination for consumers in Canada seeking our quality bio-cannabis products. Shopify's unique, industry-leading platform solutions will enable Pivot's brands to seamlessly interact with our new customers, allowing us to accelerate other growth aspects of our business," stated Pivot's CEO, Dr. Patrick Frankham .
The global legal cannabis market is projected to hit $146.4 billion by end of 2025, according to research by Grand View Research. The legal cannabis industry is gaining traction worldwide due to high demand among consumers for recreational and medical products. Recreational cannabis spending is projected to hit $35 Billion mark, while medical cannabis spending […] The post Cannabis Stock News Daily Roundup November 29 appeared first on Market Exclusive.
Pivot Naturals LLC Awarded Temporary License to Manufacture Adult and Medicinal Use Cannabis from the California Department of Public Health